Exicure (XCUR) Cash from Financing Activities (2016 - 2025)

Exicure (XCUR) reported Cash from Financing Activities of $1.6 million for Q1 2025, down 87.1% quarter-over-quarter from $12.4 million in Q4 2024.

Exicure (XCUR) Cash from Financing Activities (2016 - 2025) Analysis & Trends

Exicure has reported Cash from Financing Activities for 10 years, with the latest figure at $1.6 million in Q1 2025.

  • For the quarter ending Q1 2025, Cash from Financing Activities changed N/A year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at $1.6 million (down 88.06% YoY), and the FY2025 full-year result was $1.6 million, down 88.06% from the prior year.
  • Cash from Financing Activities for Q1 2025 stood at $1.6 million, down from $12.4 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $12.4 million in Q4 2024, with the low at -$8.0 million in Q1 2022.
  • Historically, Cash from Financing Activities has averaged $1.2 million across 5 years, with a median of $289500.0 in 2021.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 1563.92% — and 2024, when it surged 1240300.0%.
  • Exicure's Cash from Financing Activities stood at $448000.0 in 2021, then plunged by 100.45% to -$2000.0 in 2022, then jumped by 50.0% to -$1000.0 in 2023, then surged by 1240300.0% to $12.4 million in 2024, then slumped by 87.1% to $1.6 million in 2025.
  • The last three Cash from Financing Activities figures came in at $1.6 million (Q1 2025), $12.4 million (Q4 2024), and $1.0 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 7.00 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -600,000.00
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 53,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -538.80 Mn
9 Abivax 94.37 Bn 94.37 Bn - 85,464.43
10 Exicure 19.38 Mn 16.77 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 1.60 Mn
Mar 31, 2025 1.60 Mn
Dec 31, 2024 12.40 Mn
Dec 31, 2024 12.40 Mn
Jun 30, 2024 1.00 Mn
Jun 30, 2024 1.00 Mn
Dec 31, 2023 -1,000.00
Dec 31, 2023 -1,000.00
Sep 30, 2023 -1,000.00
Sep 30, 2023 -1,000.00
Jun 30, 2023 -919,000.00
Jun 30, 2023 -919,000.00
Mar 31, 2023 4.60 Mn
Mar 31, 2023 4.60 Mn
Sep 30, 2022 -2,000.00
Sep 30, 2022 -2,000.00
Jun 30, 2022 4.89 Mn
Jun 30, 2022 4.89 Mn
Mar 31, 2022 -7.99 Mn
Mar 31, 2022 -7.99 Mn